Testing effectiveness (Phase 2)Study completedNCT01752400What this trial is testingAUY922 for Advanced ALK-positive NSCLCWho this might be right forNon Small Cell Lung Cancer Massachusetts General Hospital 6
Testing effectiveness (Phase 2)Ended earlyNCT05313009What this trial is testingTarlox and Sotorasib in Patients With KRAS G12C MutationsWho this might be right forNon-Small Cell Lung Cancer Medical University of South Carolina 5
Testing effectiveness (Phase 2)Study completedNCT00653939What this trial is testingA Safety and Efficacy Study of Carboplatin, Paclitaxel, Bevacizumab and CA4P in Non-Small Cell Lung CancerWho this might be right forTumors Mateon Therapeutics 63
Early research (Phase 1)Study completedNCT00020267What this trial is testingVaccine Therapy in Treating Patients With Metastatic CancerWho this might be right forLung CancerAdult Soft Tissue SarcomaColorectal Cancer+8 more National Cancer Institute (NCI)
Testing effectiveness (Phase 2)UnknownNCT02824952What this trial is testingNeo-adjuvant Trial With AZD9291 in EGFRm+ Stage IIIA/B NSCLCWho this might be right forLung Cancer, Non-small Cell Shaare Zedek Medical Center 40
Early research (Phase 1)Ended earlyNCT05861947What this trial is testingClinical Trial of AUR106 in Patients With Relapsed Advanced MalignanciesWho this might be right forRelapseAdvanced Malignant NeoplasmNon Small Cell Lung Cancer+5 more Aurigene Discovery Technologies Limited 21
Testing effectiveness (Phase 2)Study completedNCT00621049What this trial is testingCarboplatin, Docetaxel, Bevacizumab, and Erlotinib Versus Chemotherapy Alone in Resected NSCLCWho this might be right forNon-Small Cell Lung Cancer SCRI Development Innovations, LLC 112
Testing effectiveness (Phase 2)Study completedNCT04577638What this trial is testingAccelerated Radio-Immunotherapy for Lung CancerWho this might be right forNon Small Cell Lung Cancer Stage III Center Eugene Marquis 8
Testing effectiveness (Phase 2)Active Not RecruitingNCT05445843What this trial is testingStudy of Efficacy and Safety of JDQ443 Single-agent as First-line Treatment for Patients With Locally Advanced or Metastatic KRAS G12C- Mutated Non-small Cell Lung Cancer With a PD-L1 Expression < 1% or a PD-L1 Expression ≥ 1% and an STK11 Co-mutation.Who this might be right forLocally Advanced or Metastatic KRAS G12C-mutated NSCLC With a PD-L1 Expression <1% or a PD-L1 Expression ≥ 1% and an STK11 Co-mutation Novartis Pharmaceuticals 95
Testing effectiveness (Phase 2)Ended earlyNCT02580708What this trial is testingPhase 1/2 Study of the Safety and Efficacy of Rociletinib in Combination With Trametinib in Patients With mEGFR-positive Advanced or Metastatic Non-small Cell Lung CancerWho this might be right forNon-small Cell Lung Cancer Clovis Oncology, Inc. 7
Testing effectiveness (Phase 2)Study completedNCT00986674What this trial is testingCarboplatin and Paclitaxel Combined With Cetuximab and/or IMC-A12 in Patients With Advanced Non-Small Cell Lung CancerWho this might be right forRecurrent Non-small Cell Lung CancerStage IIIB Non-small Cell Lung CancerStage IV Non-small Cell Lung Cancer National Cancer Institute (NCI) 140
Testing effectiveness (Phase 2)Active Not RecruitingNCT02955290What this trial is testingCIMAvax Vaccine, Nivolumab, and Pembrolizumab in Treating Patients With Advanced Non-small Cell Lung Cancer or Squamous Head and Neck CancerWho this might be right forAdvanced Head and Neck Squamous Cell CarcinomaLung Non-Small Cell CarcinomaMetastatic Lung Non-Small Cell Carcinoma+13 more Roswell Park Cancer Institute 51
Large-scale testing (Phase 3)Ended earlyNCT00442026What this trial is testingRandomized Trial of Docetaxel and Gemcitabine Versus Gemcitabine in Elderly Patients With NSCLCWho this might be right forNon-small-cell Lung Cancer Hellenic Oncology Research Group 106
Not applicableLooking for participantsNCT06436625What this trial is testingOutpatient Pulmonary Rehabilitation in Non-small-cell Lung Cancer Receiving ImmunotherapyWho this might be right forNSCLC Stage IV Karl Landsteiner Institute for Lung Research and Pneumological Oncology 70
Large-scale testing (Phase 3)Active Not RecruitingNCT04695925What this trial is testingOsimertinib Monotherapy or Combination With Chemotherapy for Advanced NSCLC Concurrent EGFR and TP53 MutationsWho this might be right forNon-small Cell CarcinomaEGFR Gene Mutation Li Zhang, MD 294
Testing effectiveness (Phase 2)Active Not RecruitingNCT04225117What this trial is testingEvaluate Enfortumab Vedotin in Subjects With Locally Advanced or Metastatic Malignant Solid Tumors (EV-202)Who this might be right forLocally Advanced or Metastatic Malignant Solid Tumors Astellas Pharma Global Development, Inc. 329
Not applicableStudy completedNCT01830426What this trial is testingCirculating Tumor Cells in Non-Small Cell Lung CarcinomaWho this might be right forPrimary Lung Cancer Epic Sciences 232
Testing effectiveness (Phase 2)Looking for participantsNCT05913089What this trial is testingA Clinical Study of TQB2450 Injection Combined With Chemotherapy or Anlotinib Hydrochloride Capsule in the Treatment of Non Small Cell Lung CancerWho this might be right forNon Small Cell Lung Cancer Chia Tai Tianqing Pharmaceutical Group Co., Ltd. 58
Not applicableEnded earlyNCT00840749What this trial is testingRandomized Study to Compare CyberKnife to Surgical Resection In Stage I Non-small Cell Lung CancerWho this might be right forNon-small Cell Lung Cancer Accuray Incorporated 36
Testing effectiveness (Phase 2)Looking for participantsNCT05798845What this trial is testingThe Effect of Toripalimab Plus Radiotherapy in Patients With Operable Stage II-IIIA (N+) Non Small Cell Lung CancerWho this might be right forNSCLC Shanghai Chest Hospital 124